Vanderbilt Institute for Clinical and Translational Research (VICTR)

diverse group of adults
July 5, 2016

Vanderbilt establishes Recruitment Innovation Center to increase enrollment of minorities, women and older adults in clinical trials

Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this.

By Bill Snyder
speed bump sign
July 5, 2016

New NIH-funded center to study inefficiencies in clinical trials

Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently.

By Bill Snyder
November 5, 2015

New awards honor contributions to translational research at VUMC

Two physician-scientist leaders at Vanderbilt University Medical Center were honored last week with newly created awards for helping to build and nurture Vanderbilt’s vibrant culture of clinical and translational research.

By Bill Snyder
research default banner
November 5, 2015

Initiative speeds clinical trials contract negotiations

An initiative promoted by the Vanderbilt Institute of Clinical and Translational Research (VICTR) offers an opportunity to reduce by more than half the time it takes to negotiate clinical trial contracts.

By Bill Snyder
blood draw
October 22, 2015

Revised regulations proposed for human subject research

Eighteen departments and agencies of the federal government have joined to propose revised regulations for scientific research involving human subjects.

By Paul Govern
microscope
September 10, 2015

Initiative seeks to bolster ‘rediscovery research’

The Vanderbilt Institute for Clinical and Translational Research (VICTR) is partnering with a public charity, Cures Within Reach, to encourage “rediscovery research,” the “repurposing” of already approved medical treatments to other conditions or diseases for which there are no “universally” effective therapies.

By Bill Snyder
March 28, 2014

Mapping brain circuitry

Vanderbilt investigators have used two types of neuroimaging to establish a “map” of connections for a brain region important in anxiety and addiction.
By Leigh MacMillan
October 14, 2013

Magnesium impacts vitamin D status

Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer.
By VUMC News and Communications
September 24, 2013

Twelfth annual Vanderbilt Research Retreat set for Oct. 4

The Vanderbilt community is invited to attend the 12th annual Research Retreat, a showcase of cutting-edge biomedical science by Vanderbilt faculty members and trainees.
By Bill Snyder
July 18, 2013

Data management tool developed at VU sees global growth

The number of researchers and institutions worldwide using a Vanderbilt University-developed Web application to collect and manage their data has about doubled in the past year.
By Bill Snyder
July 11, 2013

New tool helps research publications stay NIH-compliant

The National Institutes of Health requires scientists to provide public access to any peer-reviewed publications resulting from NIH-supported research through PubMed, the National Library of Medicine’s premier search system.
By Bill Snyder
April 4, 2013

Community involvement aids translational research

As Carla Sevin, M.D., assistant professor of Medicine at Vanderbilt, began the process of writing a recent grant proposal, she was stumped.
By Jessica Pasley
November 29, 2012

Symposium highlights VU’s clinical, translational research

Nearly $5 million in internal pilot grants to jumpstart research projects. A tripling in the number of clinical and translational research publications. Novel research tools that have been snapped up by scientists around the world.
By Bill Snyder
1 … 4 5 6 7 8